Cowen And Company, LLC Phathom Pharmaceuticals, Inc. Transaction History
Cowen And Company, LLC
- $0
- Q4 2024
Shares
1 transactions
Others Institutions Holding PHAT
# of Institutions
137Shares Held
61.3MCall Options Held
1.15MPut Options Held
1.05M-
Frazier Life Sciences Management, L.P. Menlo Park, CA12.5MShares$129 Million6.31% of portfolio
-
Medicxi Ventures Management (Jersey) LTD7.46MShares$77.5 Million20.28% of portfolio
-
Invesco Ltd. Atlanta, GA4.14MShares$43 Million0.01% of portfolio
-
Carlyle Group Inc. Washington, DC3.5MShares$36.3 Million41.56% of portfolio
-
Black Rock Inc. New York, NY2.93MShares$30.4 Million0.0% of portfolio
About Phathom Pharmaceuticals, Inc.
- Ticker PHAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,175,200
- Market Cap $407M
- Description
- Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...